You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Harvard Business School
Moodys
Baxter
Dow
Medtronic
Johnson and Johnson

Last Updated: June 3, 2020

DrugPatentWatch Database Preview

ABLYSINOL Drug Profile


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

When do Ablysinol patents expire, and when can generic versions of Ablysinol launch?

Ablysinol is a drug marketed by Belcher and is included in one NDA.

The generic ingredient in ABLYSINOL is alcohol. There are forty-one drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the alcohol profile page.

Summary for ABLYSINOL
Drug patent expirations by year for ABLYSINOL

US Patents and Regulatory Information for ABLYSINOL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Belcher ABLYSINOL alcohol SOLUTION;INTRA-ARTERIAL 207987-001 Jun 21, 2018 RX Yes No   Start Trial   Start Trial   Start Trial
Belcher ABLYSINOL alcohol SOLUTION;INTRA-ARTERIAL 207987-002 Jun 21, 2018 RX Yes Yes   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Moodys
Baxter
Dow
Medtronic
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.